Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Entropy Technologies LP

Entropy Technologies LP raised its position in Azenta, Inc. (NASDAQ:AZTA) by 236.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 13,085 shares of the company’s stock after acquiring an additional 9,199 shares during the period. Entropy Technologies LP’s holdings in Azenta were worth $634,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. Versor Investments LP lifted its stake in shares of Azenta by 199.1% in the 3rd quarter. Versor Investments LP now owns 15,697 shares of the company’s stock worth $760,000 after acquiring an additional 10,449 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in shares of Azenta by 9.5% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 40,008 shares of the company’s stock valued at $1,938,000 after purchasing an additional 3,469 shares in the last quarter. QRG Capital Management Inc. increased its holdings in shares of Azenta by 6.6% in the 3rd quarter. QRG Capital Management Inc. now owns 6,156 shares of the company’s stock valued at $298,000 after purchasing an additional 383 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after purchasing an additional 256 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Azenta by 1.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 36,710 shares of the company’s stock valued at $1,778,000 after purchasing an additional 700 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Trading Down 4.2 %

NASDAQ:AZTA opened at $42.63 on Friday. The firm has a 50-day moving average price of $45.68 and a two-hundred day moving average price of $50.54. Azenta, Inc. has a twelve month low of $40.24 and a twelve month high of $69.16. The company has a market capitalization of $2.09 billion, a P/E ratio of -14.35 and a beta of 1.48.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 0.98%. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period last year, the firm posted $0.13 EPS. On average, equities research analysts predict that Azenta, Inc. will post 0.42 earnings per share for the current year.

Insider Transactions at Azenta

In other news, CFO Herman Cueto sold 1,595 shares of Azenta stock in a transaction dated Thursday, October 17th. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the sale, the chief financial officer now directly owns 24,604 shares in the company, valued at $1,074,702.72. The trade was a 6.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.77% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AZTA. Needham & Company LLC cut their price target on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday. Evercore ISI cut their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $63.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.